Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy
Authors
Keywords
-
Journal
Therapeutic Advances in Medical Oncology
Volume 6, Issue 6, Pages 293-304
Publisher
SAGE Publications
Online
2014-08-02
DOI
10.1177/1758834014544891
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer
- (2014) Jason D. Wright et al. CANCER
- Role of neoadjuvant chemotherapy in the management of advanced ovarian yolk sac tumor
- (2014) Yan Lu et al. GYNECOLOGIC ONCOLOGY
- TP53 K351N mutation-associated platinum resistance after neoadjuvant chemotherapy in patients with advanced ovarian cancer
- (2014) Guo-nan Zhang et al. GYNECOLOGIC ONCOLOGY
- Histologic Parameters Predictive of Disease Outcome in Women with Advanced Stage Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy
- (2014) Damanzoopinder Samrao et al. Translational Oncology
- Progress in Survival Outcomes in Patients with Advanced Ovarian Cancer Treated by Neo-Adjuvant Platinum/Taxane-Based Chemotherapy and Late Interval Debulking Surgery
- (2013) Eberhard Stoeckle et al. ANNALS OF SURGICAL ONCOLOGY
- Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial
- (2013) Hannah S. van Meurs et al. EUROPEAN JOURNAL OF CANCER
- Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery?
- (2013) Michael J. Worley et al. GYNECOLOGIC ONCOLOGY
- Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy
- (2013) Elfriede Greimel et al. GYNECOLOGIC ONCOLOGY
- Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery
- (2013) Miho Muraji et al. GYNECOLOGIC ONCOLOGY
- Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma
- (2013) J. Alejandro Rauh-Hain et al. GYNECOLOGIC ONCOLOGY
- Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary
- (2013) Shobhana Talukdar et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness
- (2013) Vanessa da Costa Miranda et al. GYNECOLOGIC ONCOLOGY
- Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients? A nationwide Danish study
- (2013) Carsten Lindberg Fagö-Olsen et al. GYNECOLOGIC ONCOLOGY
- Morbidity of Surgery After Neoadjuvant Chemotherapy Including Bevacizumab for Advanced Ovarian Cancer
- (2013) Elisabeth Chéreau et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining ‘optimal’ residual disease
- (2012) Suk-Joon Chang et al. GYNECOLOGIC ONCOLOGY
- Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy?
- (2012) Johanna Hynninen et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?
- (2012) Ignace Vergote et al. GYNECOLOGIC ONCOLOGY
- Role of Neoadjuvant Chemotherapy in the Management of Stage IIIC–IV Ovarian Cancer
- (2012) Sarah Cornelis et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV)
- (2012) Michelle A. Glasgow et al. JOURNAL OF SURGICAL ONCOLOGY
- Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer
- (2011) J. Alejandro Rauh-Hain et al. ANNALS OF SURGICAL ONCOLOGY
- Bevacizumab and ovarian cancer
- (2011) Shinya Sato et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer
- (2011) Ignace Vergote et al. EUROPEAN JOURNAL OF CANCER
- An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)
- (2011) Dennis S. Chi et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant Chemotherapy Is the Better Treatment Option in Some Patients With Stage IIIc to IV Ovarian Cancer
- (2011) Ignace Vergote et al. JOURNAL OF CLINICAL ONCOLOGY
- Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial
- (2011) Sandro Pignata et al. JOURNAL OF CLINICAL ONCOLOGY
- Early versus delayed treatment of relapsed ovarian cancer
- (2011) Gordon Rustin et al. LANCET
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prediction of Chemotherapy Response With Platinum and Taxane in the Advanced Stage of Ovarian and Uterine Carcinosarcoma
- (2010) Koji Matsuo et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Estimates of cancer incidence and mortality in Europe in 2008
- (2010) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Ovarian cancer in the elderly: Outcomes with neoadjuvant chemotherapy or primary cytoreduction
- (2010) Kate A. McLean et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant Chemotherapy Is Associated With Prolonged Primary Treatment Intervals in Patients With Advanced Epithelial Ovarian Cancer
- (2010) Michael R. Milam et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Residual Cancer Stem Cells after Interval Cytoreductive Surgery following Neoadjuvant Chemotherapy Could Result in Poor Treatment Outcomes for Ovarian Cancer
- (2010) Myong Cheol Lim et al. ONKOLOGIE
- Does Neoadjuvant Chemotherapy Increase Optimal Cytoreduction Rate in Advanced Ovarian Cancer? Meta-Analysis of 21 Studies
- (2009) Sokbom Kang et al. ANNALS OF SURGICAL ONCOLOGY
- Chemotherapy time interval and development of platinum and taxane resistance in ovarian, fallopian, and peritoneal carcinomas
- (2009) Koji Matsuo et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- Clinicopathological characteristics of mucinous adenocarcinoma of the ovary
- (2009) Muneaki Shimada et al. GYNECOLOGIC ONCOLOGY
- Contemporary considerations for neoadjuvant chemotherapy in primary ovarian cancer
- (2009) Peter E. Schwartz Current Oncology Reports
- Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival
- (2008) J D Wright et al. BRITISH JOURNAL OF CANCER
- Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: A potential treatment strategy
- (2008) Seiya Sato et al. CANCER SCIENCE
- A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma
- (2008) Dennis S. Chi et al. GYNECOLOGIC ONCOLOGY
- Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia
- (2007) Agustin A. Garcia et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started